HYDRIX Trademark

Trademark Overview

On Wednesday, February 22, 2023, a trademark application was filed for HYDRIX with the United States Patent and Trademark Office. The USPTO has given the HYDRIX trademark a serial number of 97807095. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, October 29, 2024. This trademark is owned by Caldera Medical, Inc.. The HYDRIX trademark is filed in the Pharmaceutical Products category with the following description:

Biologic Implants, namely, allograft and xenograft biological tissue intended for subsequent implantation
hydrix

General Information

Serial Number97807095
Word MarkHYDRIX
Filing DateWednesday, February 22, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2024

Trademark Statements

Goods and ServicesBiologic Implants, namely, allograft and xenograft biological tissue intended for subsequent implantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCaldera Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361
Party NameCaldera Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAgoura Hills, CA 91301

Trademark Events

Event DateEvent Description
Saturday, February 25, 2023NEW APPLICATION ENTERED
Monday, March 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 20, 2023ASSIGNED TO EXAMINER
Monday, November 20, 2023NON-FINAL ACTION WRITTEN
Monday, November 20, 2023NON-FINAL ACTION E-MAILED
Monday, November 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 24, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 25, 2024ASSIGNED TO LIE
Thursday, January 25, 2024EXAMINER'S AMENDMENT ENTERED
Friday, January 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU EXTENSION 1 GRANTED
Tuesday, October 29, 2024SOU EXTENSION 1 FILED

Related Keywords

hydrix tissue intended subsequent implantation biological xenograft implants namely allograft biologic